Circulating tumor DNA can help differentiate pseudoprogression from true progression in patients with melanoma who are treated with PD-1 inhibitors.
In a Belgian study, integration of palliative care as part of cancer care increased the quality of life of patients…
Patients with ER-negative, but not ER-positive, isolated locoregional recurrence after unilateral breast cancer derive significant benefit from chemotherapy.
The observed narrowing of racial disparities in prostate cancer outcome since the advent of PSA screening is not as large…
A retrospective review found that obesity is associated with improved progression-free and overall survival in certain patients with metastatic melanoma.
Single-agent ibrutinib resulted in sustained efficacy and durable responses in treatment-naive or relapsed/refractory CLL or SLL, 5-year results show.